Amgen Inc.
LYOPHILIZED VIRUS FORMULATIONS
Last updated:
Abstract:
Provided herein is a powder comprising a live, attenuated virus, recombinant human serum albumin (rHSA), a sugar other than lactose, a sugar alcohol, a source of phosphate, a source of chloride, wherein the composition is substantially free of lactose, gelatin, antibiotic, and free amino acids. In exemplary aspects, the powder is a lyophilizate of a liquid composition. Related liquid compositions, methods of preparing an oncolytic virus for administration and methods of treating melanoma are also provided herein.
Status:
Application
Type:
Utility
Filling date:
27 Dec 2019
Issue date:
23 Jun 2022